Authors:
Acquati, F
Morelli, C
Cinquetti, R
Bianchi, MG
Porrini, D
Varesco, L
Gismondi, V
Rocchetti, R
Talevi, S
Possati, L
Magnanini, C
Tibiletti, MG
Bernasconi, B
Daidone, MG
Shridhar, V
Smith, DI
Negrini, M
Barbanti-Brodano, G
Taramelli, R
Citation: F. Acquati et al., Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27, ONCOGENE, 20(8), 2001, pp. 980-988
Authors:
Shridhar, V
Lee, J
Pandita, A
Iturria, S
Avula, R
Staub, J
Morrissey, M
Calhoun, E
Sen, A
Kalli, K
Keeney, G
Roche, P
Cliby, W
Lu, K
Schmandt, R
Mills, GB
Bast, RC
James, CD
Couch, FJ
Hartmann, LC
Lillie, J
Smith, DI
Citation: V. Shridhar et al., Genetic analysis of early- versus late-stage ovarian tumors, CANCER RES, 61(15), 2001, pp. 5895-5904
Authors:
Shridhar, V
Bible, KC
Staub, J
Avula, R
Lee, YK
Kalli, K
Huang, HJ
Hartmann, LC
Kaufmann, SH
Smith, DI
Citation: V. Shridhar et al., Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer, CANCER RES, 61(10), 2001, pp. 4258-4265
Authors:
Kawakami, M
Staub, J
Cliby, W
Hartmann, L
Smith, DI
Shridhar, V
Citation: M. Kawakami et al., Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer, INT J ONCOL, 15(4), 1999, pp. 715-720
Authors:
Shridhar, V
Staub, J
Huntley, B
Cliby, W
Jenkins, R
Pass, HI
Hartmann, L
Smith, DI
Citation: V. Shridhar et al., A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancer, ONCOGENE, 18(26), 1999, pp. 3913-3918
Authors:
Huang, HJ
Reed, CP
Zhang, JS
Shridhar, V
Wang, L
Smith, DI
Citation: Hj. Huang et al., Carboxypeptidase A3 (CPA3): A novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells, CANCER RES, 59(12), 1999, pp. 2981-2988
Authors:
Ohta, Y
Shridhar, V
Bright, RK
Kalemkerian, GP
Du, W
Carbone, M
Watanabe, Y
Pass, HI
Citation: Y. Ohta et al., VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours, BR J CANC, 81(1), 1999, pp. 54-61